Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt - Concepedia

Concepedia

Publication | Open Access

Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt

DOI Full Paper Access

124

Citations

29

References

2017

Year

Heba Omar, Wafaa Elakel, Tamer Elbaz, Mohamed El‐Kassas, Kadry Elsaeed, Hewaida El Shazly, Mohamed Said, Monkez Yousif, Ahmed Gomaa, Ahmed Nasr,

Alimentary Pharmacology & Therapeutics

Abstract

Real-world experience of generic SOF-DCV in patients with chronic HCV-G4 proved to be safe and associated with a high SVR12 rate, in patients with different stages of fibrosis.

References

	Year	Citations

Page 1